CATH Search:   
       by CATH code, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Alpha Beta (26913)
(-)
Architecture: Alpha-Beta Complex (3881)
(-)
Topology: Cathepsin B; Chain A (207)
(-)
Homologous Superfamily: Cysteine proteinases (207)
(-)
Human (Homo sapiens) (92)
1ATKA:1-215CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR E-64
1AU0A:1-215CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT SYMMETRIC DIACYLAMINOMETHYL KETONE INHIBITOR
1AU2A:1-215CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PROPANONE INHIBITOR
1AU3A:1-215CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PYRROLIDINONE INHIBITOR
1AU4A:1-215CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PYRROLIDINONE INHIBITOR
1AYUA:1-215CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT SYMMETRIC BISCARBOHYDRAZIDE INHIBITOR
1AYVA:1-215CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT THIAZOLHYDRAZIDE INHIBITOR
1AYWA:1-215CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT BENZYLOXYBENZOYLCARBOHYDRAZIDE INHIBITOR
1BGOA:1-215CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PEPTIDOMIMETIC INHIBITOR
1BY8A:5-314THE CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN K
1CB5A:54-454; B:54-454; C:54-454HUMAN BLEOMYCIN HYDROLASE.
1CJLA:5P-220CRYSTAL STRUCTURE OF A CYSTEINE PROTEASE PROFORM
1CS8A:1P-220CRYSTAL STRUCTURE OF PROCATHEPSIN L
1CSBB:50-254; E:50-254CRYSTAL STRUCTURE OF CATHEPSIN B INHIBITED WITH CA030 AT 2.1 ANGSTROMS RESOLUTION: A BASIS FOR THE DESIGN OF SPECIFIC EPOXYSUCCINYL INHIBITORS
1DEUB:4P-242; A:6P-242CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN X: A CYSTEINE PROTEASE WITH THE PROREGION COVALENTLY LINKED TO THE ACTIVE SITE CYSTEINE
1EF7A:1-242; B:1-242CRYSTAL STRUCTURE OF HUMAN CATHEPSIN X
1FH0A:1-220; B:2001-2220CRYSTAL STRUCTURE OF HUMAN CATHEPSIN V COMPLEXED WITH AN IRREVERSIBLE VINYL SULFONE INHIBITOR
1GLOA:1-217CRYSTAL STRUCTURE OF CYS25SER MUTANT OF HUMAN CATHEPSIN S
1GMYB:0-252; C:0-252; A:0-253CATHEPSIN B COMPLEXED WITH DIPEPTIDYL NITRILE INHIBITOR
1HUCB:50-254; D:50-254THE REFINED 2.15 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF HUMAN LIVER CATHEPSIN B: THE STRUCTURAL BASIS FOR ITS SPECIFICITY
1ICFA:1-175; C:1-175CRYSTAL STRUCTURE OF MHC CLASS II ASSOCIATED P41 II FRAGMENT IN COMPLEX WITH CATHEPSIN L
1K3BB:215-358CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE I (CATHEPSIN C): EXCLUSION DOMAIN ADDED TO AN ENDOPEPTIDASE FRAMEWORK CREATES THE MACHINE FOR ACTIVATION OF GRANULAR SERINE PROTEASES
1M6DA:1-212; B:1-212CRYSTAL STRUCTURE OF HUMAN CATHEPSIN F
1MEMA:1-211CRYSTAL STRUCTURE OF CATHEPSIN K COMPLEXED WITH A POTENT VINYL SULFONE INHIBITOR
1MHWA:1-174; B:1-174DESIGN OF NON-COVALENT INHIBITORS OF HUMAN CATHEPSIN L. FROM THE 96-RESIDUE PROREGION TO OPTIMIZED TRIPEPTIDES
1MS6A:1-217DIPEPTIDE NITRILE INHIBITOR BOUND TO CATHEPSIN S.
1NL6A:1-215; B:1-215CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT AZEPANONE INHIBITOR
1NLJA:1-215; B:1-215CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT AZEPANONE INHIBITOR
1NPZA:1-217; B:251-467CRYSTAL STRUCTURES OF CATHEPSIN S INHIBITOR COMPLEXES
1NQCA:1-217CRYSTAL STRUCTURES OF CATHEPSIN S INHIBITOR COMPLEXES
1PBHA:1A-254CRYSTAL STRUCTURE OF HUMAN RECOMBINANT PROCATHEPSIN B AT 3.2 ANGSTROM RESOLUTION
1Q6KA:1-215CATHEPSIN K COMPLEXED WITH T-BUTYL(1S)-1-CYCLOHEXYL-2-OXOETHYLCARBAMATE
1SNKA:2-215CATHEPSIN K COMPLEXED WITH CARBAMATE DERIVATIZED NORLEUCINE ALDEHYDE
1TU6A:115-329; B:115-329CATHEPSIN K COMPLEXED WITH A KETOAMIDE INHIBITOR
1U9VA:1-215CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABE854
1U9WA:0-215CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABI491
1U9XA:0-215CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABJ688
1VSNA:1-211CRYSTAL STRUCTURE OF A POTENT SMALL MOLECULE INHIBITOR BOUND TO CATHEPSIN K
1YK7A:1-215CATHEPSIN K COMPLEXED WITH A CYANOPYRROLIDINE INHIBITOR
1YK8A:117-329CATHEPSIN K COMPLEXED WITH A CYANAMIDE-BASED INHIBITOR
1YT7A:2-215CATHEPSIN K COMPLEXED WITH A CONSTRAINED KETOAMIDE INHIBITOR
2ATOA:1-215CRYSTAL STRUCTURE OF HUMAN CATHEPSIN K IN COMPLEX WITH MYOCRISIN
2AUXA:3-215CATHEPSIN K COMPLEXED WITH A SEMICARBAZONE INHIBITOR
2AUZA:1-215CATHEPSIN K COMPLEXED WITH A SEMICARBAZONE INHIBITOR
2BDLA:1-215CATHEPSIN K COMPLEXED WITH A PYRROLIDINE KETOAMIDE-BASED INHIBITOR
2C0YA:3-316THE CRYSTAL STRUCTURE OF A CYS25ALA MUTANT OF HUMAN PROCATHEPSIN S
2CB5A:54-454; B:54-454HUMAN BLEOMYCIN HYDROLASE, C73S/DELE455 MUTANT
2DJFB:215-358CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE I (CATHEPSIN C) IN COMPLEX WITH THE INHIBITOR GLY-PHE-CHN2
2DJGB:215-358RE-DETERMINATION OF THE NATIVE STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE I (CATHEPSIN C)
2F1GA:-2-217; B:1-217CATHEPSIN S IN COMPLEX WITH NON-COVALENT 2-(BENZOXAZOL-2-YLAMINO)-ACETAMIDE
2FQ9A:0-218; B:1-218CATHEPSIN S WITH NITRILE INHIBITOR
2FRAB:0-218; A:1-218HUMAN CATHEPSIN S WITH CRA-27934, A NITRILE INHIBITOR
2FRQA:0-218; B:1-218HUMAN CATHEPSIN S WITH INHIBITOR CRA-26871
2FT2B:0-218; A:1-218HUMAN CATHEPSIN S WITH INHIBITOR CRA-29728
2FUDA:0-218; B:1-218HUMAN CATHEPSIN S WITH INHIBITOR CRA-27566
2FYEA:1-211MUTANT HUMAN CATHEPSIN S WITH IRREVERSIBLE INHIBITOR CRA-14013
2G6DA:1-211HUMAN CATHEPSIN S MUTANT WITH VINYL SULFONE INHIBITOR CRA-14009
2G7YB:0-218; A:1-218HUMAN CATHEPSIN S WITH INHIBITOR CRA-16981
2H7JA:0-217; B:1-217CRYSTAL STRUCTURE OF CATHEPSIN S IN COMPLEX WITH A NONPEPTIDIC INHIBITOR.
2HH5A:1-217; B:1-217CRYSTAL STRUCTURE OF CATHEPSIN S IN COMPLEX WITH A ZINC MEDIATED NON-COVALENT ARYLAMINOETHYL AMIDE
2HHNA:-2-217; B:1-217CATHEPSIN S IN COMPLEX WITH NON COVALENT ARYLAMINOETHYL AMIDE.
2HXZB:0-217; A:1-217; C:1-217CRYSTAL STRUCTURE OF CATHEPSIN S IN COMPLEX WITH A NONPEPTIDIC INHIBITOR (HEXAGONAL SPACEGROUP)
2IPPB:50-254CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF HUMAN LIVER CATHEPSIN B
2OP3A:1-217; B:1-217THE STRUCTURE OF CATHEPSIN S WITH A NOVEL 2-ARYLPHENOXYACETALDEHYDE INHIBITOR DERIVED BY THE SUBSTRATE ACTIVITY SCREENING (SAS) METHOD
2PBHA:1A-254CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN B AT 3.3 ANGSTROM RESOLUTION
2R6NA:0-215CRYSTAL STRUCTURE OF A PYRROLOPYRIMIDINE INHIBITOR IN COMPLEX WITH HUMAN CATHEPSIN K
2R9MA:1-217; B:1-217CATHEPSIN S COMPLEXED WITH COMPOUND 15
2R9NA:1-217; B:1-217CATHEPSIN S COMPLEXED WITH COMPOUND 26
2R9OA:1-217; B:1-217CATHEPSIN S COMPLEXED WITH COMPOUND 8
2VHSA:1-220; B:1-220; C:1-220; D:1-220CATHSILICATEIN, A CHIMERA
3BC3A:1-220; B:1-220EXPLORING INHIBITOR BINDING AT THE S SUBSITES OF CATHEPSIN L
3C9EA:1-215CRYSTAL STRUCTURE OF THE CATHEPSIN K : CHONDROITIN SULFATE COMPLEX.
3CBJA:60P-255CHAGASIN-CATHEPSIN B COMPLEX
3CBKA:61P-255CHAGASIN-CATHEPSIN B
3H6SA:1-221; B:1-221; C:1-221; D:1-221STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX
3H7DA:1-215; E:1-215THE CRYSTAL STRUCTURE OF THE CATHEPSIN K VARIANT M5 IN COMPLEX WITH CHONDROITIN-4-SULFATE
3H89A:1-220; B:1-220; C:1-220; D:1-220; E:1-220; F:1-220A COMBINED CRYSTALLOGRAPHIC AND MOLECULAR DYNAMICS STUDY OF CATHEPSIN-L RETRO-BINDING INHIBITORS(COMPOUND 4)
3H8BA:1-220; B:1-220; C:1-220; D:1-220; E:1-220; F:1-220A COMBINED CRYSTALLOGRAPHIC AND MOLECULAR DYNAMICS STUDY OF CATHEPSIN-L RETRO-BINDING INHIBITORS(COMPOUND 9)
3H8CA:1-220; B:1-220A COMBINED CRYSTALLOGRAPHIC AND MOLECULAR DYNAMICS STUDY OF CATHEPSIN-L RETRO-BINDING INHIBITORS (COMPOUND 14)
3HHAA:1-220; D:1-220; B:1-220; C:1-220CRYSTAL STRUCTURE OF CATHEPSIN L IN COMPLEX WITH AZ12878478
3HWNC:1-220; B:1-220; D:1-220; A:1-220CATHEPSIN L WITH AZ13010160
3IEJA:-1-219; B:0-220PYRAZOLE-BASED CATHEPSIN S INHIBITORS WITH ARYLALKYNES AS P1 BINDING ELEMENTS
3IV2A:2-220; B:1-220CRYSTAL STRUCTURE OF MATURE APO-CATHEPSIN L C25A MUTANT
3K24A:1-220; B:1-220CRYSTAL STRUCTURE OF MATURE APO-CATHEPSIN L C25A MUTANT IN COMPLEX WITH GLN-LEU-ALA PEPTIDE
3K9MA:1-254; B:1-254CATHEPSIN B IN COMPLEX WITH STEFIN A
3KW9A:1-215X-RAY STRUCTURE OF CATHEPSIN K COVALENTLY BOUND TO A TRIAZINE LIGAND
3KWBX:1001-1215; Y:2006-2215STRUCTURE OF CATK COVALENTLY BOUND TO A DIOXO-TRIAZINE INHIBITOR
3KWNA:1-219; B:1-219CATHEPSIN S IN COMPLEX WITH THIOETHER ACETAMIDE P3 INHIBITOR
3KWZA:1-215CATHEPSIN K IN COMPLEX WITH A NON-SELECTIVE 2-CYANO-PYRIMIDINE INHIBITOR
3KX1A:3-215CATHEPSIN K IN COMPLEX WITH A SELECTIVE 2-CYANO-PYRIMIDINE INHIBITOR
3PBHA:1A-254REFINED CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN B AT 2.5 ANGSTROM RESOLUTION
7PCKD:1P-215; C:1P-215; B:1P-215; A:1P-215CRYSTAL STRUCTURE OF WILD TYPE HUMAN PROCATHEPSIN K